CN108997197A - A kind of cyano carbazole analog derivative and its synthetic method - Google Patents
A kind of cyano carbazole analog derivative and its synthetic method Download PDFInfo
- Publication number
- CN108997197A CN108997197A CN201810940607.6A CN201810940607A CN108997197A CN 108997197 A CN108997197 A CN 108997197A CN 201810940607 A CN201810940607 A CN 201810940607A CN 108997197 A CN108997197 A CN 108997197A
- Authority
- CN
- China
- Prior art keywords
- aryl
- cyano
- alkyl
- synthetic method
- alkoxy
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
- 0 C[n](c1ccccc11)c2c1c(O)c(C(*)O)c(*I)*2C#N Chemical compound C[n](c1ccccc11)c2c1c(O)c(C(*)O)c(*I)*2C#N 0.000 description 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/56—Ring systems containing three or more rings
- C07D209/80—[b, c]- or [b, d]-condensed
- C07D209/82—Carbazoles; Hydrogenated carbazoles
- C07D209/88—Carbazoles; Hydrogenated carbazoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to carbon atoms of the ring system
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
Landscapes
- Health & Medical Sciences (AREA)
- Organic Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Pharmacology & Pharmacy (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Communicable Diseases (AREA)
- Oncology (AREA)
- Virology (AREA)
- Indole Compounds (AREA)
Abstract
The invention discloses a kind of synthetic methods of cyano carbazole analog derivative, and using indoles acetylenic ketone compounds and alpha-cyano ketone compounds as raw material, " one kettle way " synthesizes the cyano carbazole analog derivative as shown in formula (I).The synthetic method is specifically, the first step realizes C-C σ-bond activation of alpha-cyano ketone by promotor;C-H and/or C-C bond activation selectively occurs under the catalysis of the catalyst for second step.Preparation method of the present invention has many advantages, such as that raw material is simple and easy to get, universality is good, post-processing is easy, yield is good, environmentally friendly.The present invention also provides application of formula (I) the cyano carbazole analog derivative in drug.
Description
Technical field
The invention belongs to organic compound and the technical field of synthesis, it is related to a kind of cyano carbazole analog derivative and its synthesis
Method.
Background technique
Cyano carbazole analog derivative is a kind of important organic compound, is primary structure in many natural products and drug
Unit, and there is stronger bioactivity mostly.It can be used for organic synthesis intermediate, there is great valence in terms of pharmaceutical synthesis
Value.Carbazole compound is a kind of important nitrogen heterocyclic, has special rigid condensed cyclic structure.Carbazole compound knot
Structure, which has the following characteristics that, is easily formed metastable cation;Intramolecular has biggish conjugated system and strong intramolecular
Electronics transfer;Universal thermal stability and photochemical stability with higher;It is easy to carry out a variety of functional groups of structural modification introducing;
Carbazole compound itself is one of coai-tar product, and raw material is easy to get.This special construction of carbazole makes it as a kind of important conjunction
At intermediate, it is widely used in organic synthesis field.Carbazole compound is widely present in natural products, such most chemical combination
Object has significant bioactivity, plays an important role in field of medicaments, can be used for protein kinase and topoisomerase inhibits
The research such as agent, bariatrician, anti-inflammatory, antiviral and anti-tumor drug.
Therefore, people have been attracted widely to pay close attention to the study on the synthesis of carbazole compound.Currently, there are many related carbazoles
The report of synthetic method.Such as: document (1) Kong, W.;Fu,C.;Ma,S.Chem.Commun.2009,4572-4574;(2)
Yuan,Z.-G.;Wang,Q.;Zheng,A.;Zhang,K.;Lu,L-Q.;Tang,Z.;Xiao,W.-
J.Chem.Commun.2016,52,5128-5131.But the prior art also has shortcoming, such as reaction raw materials are not easy to obtain
, catalyst is expensive and functional group compatibility is relatively narrow etc..Therefore, it is still necessary to develop more economical, easy and reaction item
The mild synthetic method of part.
Summary of the invention
Promote to select under lower generation C-C cleavage reaction and catalyst the object of the present invention is to provide a kind of promotor
The tandem reaction of C-H and/or C-C bond activation reaction, preparation method of the present invention simple and easy to get, universality with raw material occur for selecting property
Well, the advantages that post-processing is easy, yield is good, environmentally friendly.
The invention also provides a kind of preparation method of cyano carbazole analog derivative shown in formula (I), with indoles acetylenic ketone and
Alpha-cyano ketone compounds are raw material, and under the effect of catalyst, promotor and oxidant, synthesis obtains the cyanogen as shown in formula (I)
Base carbazole analog derivative.
The invention proposes a kind of cyano carbazole analog derivatives, shown in structure such as formula (I):
Wherein,
R1For electrophilic or electron substituent group, it is selected from aryl, aryl, the halogen that alkyl-substituted aryl, alkoxy replace
The aryl or alkyl of aryl, cyano substitution that element replaces;
R2For aryl, hydrogen, halogen, alkyl or alkoxy;
R3The aryl or alkyl that aryl, the halogen replaced for aryl, alkyl-substituted aryl, alkoxy replaces.
Preferably,
R1For electrophilic or electron substituent group, it is selected from phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy take
The aryl or C1-C10 alkyl that aryl, the cyano that aryl, the halogen in generation replace replace;
R2For phenyl, hydrogen, halogen, C1-C10 alkyl or C1-C10 alkoxy;
R3For phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy replace aryl, halogen replace aryl or
C1-C10 alkyl.
It is further preferred that
R1For phenyl, p-methoxyphenyl;
R2For methyl, chlorine, bromine;
R3For p-methylphenyl, p-fluorophenyl, rubigan.
The invention proposes a kind of preparation method of cyano carbazole analog derivative shown in formula (I), the first steps, in solvent
In, using indoles acetylenic ketone compounds and alpha-cyano ketone compounds as raw material, C-C σ-bond activation occurs under promotor effect and obtains
To scission of link reaction intermediate;Second step, is added oxidant and catalyst, and selectivity occurs C-H and/or C-C bond activation, synthesizes
To the cyano carbazole analog derivative as shown in formula (I):
Its reaction process is as shown in reaction formula (II):
Wherein,
R1For electrophilic or electron substituent group, aryl, the halogen replaced selected from aryl, alkyl-substituted aryl, alkoxy
The aryl or alkyl of aryl, cyano substitution that element replaces;
R2For aryl, hydrogen, halogen, alkyl or alkoxy;
R3The aryl or alkyl that aryl, the halogen replaced for aryl, alkyl-substituted aryl, alkoxy replaces.
Preferably,
R1For electrophilic or electron substituent group, it is selected from phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy take
The aryl or C1-C10 alkyl that aryl, the cyano that aryl, the halogen in generation replace replace;
R2For phenyl, hydrogen, halogen, C1-C10 alkyl or C1-C10 alkoxy;
R3For phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy replace aryl, halogen replace aryl or
C1-C10 alkyl.
It is further preferred that
R1For phenyl, p-methoxyphenyl;
R2For methyl, chlorine, bromine;
R3For p-methylphenyl, p-fluorophenyl, rubigan.
In the present invention, the indoles acetylenic ketone compounds include the acetylenic ketone for being connected with electron-withdrawing group on phenyl ring, are connected on phenyl ring
The acetylenic ketone of electron-donating group;The alpha-cyano ketone compounds include cyano ketone compounds, the benzene that electron-withdrawing group is had on phenyl ring
The cyano ketone compounds and alkyl-substituted alpha-cyano ketone compounds of electron-donating group are connected on ring.
In the present invention, the promotor is alkali, is selected from DBACO, K2CO3、Cs2CO3Deng one of or it is a variety of;Preferably,
The promotor is Cs2CO3。
In the present invention, the catalyst is one of copper catalyst, iron catalyst etc. or a variety of, is selected from FeBr2、
FeCl3、CuBr2Deng one of or it is a variety of;It preferably, is FeBr2。
In the present invention, the oxidant is peroxide, is selected from K2S2O8、(NH4)2S2O8, one of TBHP etc. or more
Kind;It preferably, is (NH4)2S2O8。
In the present invention, the indoles acetylenic ketone compounds: alpha-cyano ketone compounds: promotor: catalyst: oxidant
Molar ratio is 1.0:1.1:(1.5-3.0): (0.03-0.1): (2.0-4.0);Preferably, the indoles acetylenic ketone compounds: α-
Cyano ketone compounds: promotor: catalyst: the molar ratio of oxidant is 1.0:1.1:1.5:0.05:3.0;1.0:1.1:
2.0:0.05:3.0;1.0:1.1:3.0:0.05:3.0;1.0:1.1:2.0:0.03:3.0;1.0:1.1:2.0:0.1:3.0;
1.0:1.1:2.0:0.05:2.0;1.0:1.1:2.0:0.05:4.0;It is further preferred that the indoles acetylenic ketone compounds:
Alpha-cyano ketone compounds: promotor: catalyst: the molar ratio of oxidant is 1.0:1.1:2.0:0.05:3.0.
In the present invention, the solvent is n,N-Dimethylformamide, in n,N-dimethylacetamide, dimethyl sulfoxide, toluene
It is one or more;It preferably, is n,N-Dimethylformamide.
In the present invention, the temperature reacted in the first step is 80 DEG C -100 DEG C;It preferably, is 100 DEG C.
In the present invention, the time reacted in the first step is 2.5 hours;Preferably, it is reacted 2.5 hours for 100 DEG C.
In the present invention, the temperature reacted in the second step is 40-80 DEG C;It preferably, is 40 DEG C, 60 DEG C, 80 DEG C;Into one
Step is 60 DEG C preferably.
In the present invention, in the second step, the time of the reaction is 3 hours;Preferably, it is reacted 3 hours for 60 DEG C.
In the present invention, the yield of the preparation method is 25-77%.
In the present invention, the reaction preferably carries out under a nitrogen.
It is preferably carried out in scheme at one, shown in synthetic method following reaction formula of the present invention:
Wherein,
R1For electrophilic or electron substituent group, aryl, the halogen replaced selected from aryl, alkyl-substituted aryl, alkoxy
The aryl or alkyl of aryl, cyano substitution that element replaces;
R2For aryl, hydrogen, halogen, alkyl or alkoxy;
R3The aryl or alkyl that aryl, the halogen replaced for aryl, alkyl-substituted aryl, alkoxy replaces.
Preferably,
R1For electrophilic or electron substituent group, taken selected from phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy
The aryl or C1-C10 alkyl that aryl, the cyano that aryl, the halogen in generation replace replace;
R2For phenyl, hydrogen, halogen, C1-C10 alkyl or C1-C10 alkoxy;
R3For phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy replace aryl, halogen replace aryl or
C1-C10 alkyl.
It is further preferred that
R1For phenyl, p-methoxyphenyl;
R2For methyl, chlorine, bromine;
R3For p-methylphenyl, p-fluorophenyl, rubigan.
In a specific embodiment, in preparation method of the present invention, with Cs2CO3For promotor, FeBr2For catalyst,
As shown in following formulas (II-2):
Wherein,
R1For electrophilic or electron substituent group, aryl, the halogen replaced selected from aryl, alkyl-substituted aryl, alkoxy
The aryl or alkyl of aryl, cyano substitution that element replaces;
R2For aryl, hydrogen, halogen, alkyl or alkoxy;
R3The aryl or alkyl that aryl, the halogen replaced for aryl, alkyl-substituted aryl, alkoxy replaces.
Preferably,
R1For electrophilic or electron substituent group, taken selected from phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy
The aryl or C1-C10 alkyl that aryl, the cyano that aryl, the halogen in generation replace replace;
R2For phenyl, hydrogen, halogen, C1-C10 alkyl or C1-C10 alkoxy;
R3For phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy replace aryl, halogen replace aryl or
C1-C10 alkyl.
It is further preferred that
R1For phenyl, p-methoxyphenyl;
R2For methyl, chlorine, bromine;
R3For p-methylphenyl, p-fluorophenyl, rubigan.
Reaction principle of the invention are as follows: the first step realizes C-C σ-bond activation of alpha-cyano ketone by promotor;Second step exists
C-H and/or C-C bond activation occurs for the lower selectivity of catalyst effect.
The invention also provides cyano carbazole analog derivatives to prepare anti-tumor activity and antibacterial and antiviral activity drug
In application.
Cyano carbazole analog derivative be present invention firstly provides noval chemical compound, until so far, there are no relevant report.
Cyano carbazole analog derivative proposed by the present invention is essential building blocks in many natural products and drug, is had mostly stronger
Bioactivity.It can be used for organic synthesis intermediate, there is substantial worth in terms of pharmaceutical synthesis.Therefore, people are to cyano carbazole
The study on the synthesis of analog derivative gives many concerns.
The present invention includes the following advantages: Material synthesis is easy, and promotor and catalyst used are environmentally friendly.This hair
Bright synthetic reaction universality is good, raw material is simple and easy to get, post-processing is easy, yield is good, environmentally friendly.
Specific embodiment
In conjunction with following specific embodiments, the present invention is described in further detail, and of the invention protects content not limit to
In following embodiment.Without departing from the spirit and scope of the invention, those skilled in the art it is conceivable that variation and excellent
Point is all included in the present invention, and using appended claims as protection scope.Implement process of the invention, condition,
Reagent, experimental method etc. are among the general principles and common general knowledge in the art, this hair in addition to what is specifically mentioned below
It is bright that there are no special restrictions to content.
Embodiment 1, the synthesis of IA
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
Acetylene indol-2-one, 2- cyano-acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the dosage of raw material is respectively
Phenylacetylene indol-2-one 0.3mmol, 2- cyano-acetophenone 0.33mmol, Cs2CO30.6mmol, solvent dimethyl sulfoxide 3ml,
100 DEG C are reacted 2.5 hours, are then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate 0.9mmol is added, is placed in 60
It is reacted 3 hours at DEG C, obtains target product formula (IA), yellow solid, separation yield 73%.Mp 273-275℃.
Nuclear magnetic data:1H NMR(400MHz,CDCl3)δ4.27(s,3H),7.03-7.11(m,5H),7.17-7.26(m,
5H), 7.39-7.43 (m, 1H), 7.48-7.50 (m, 1H), 7.55-7.60 (m, 1H), 8.44 (d, J=7.6Hz, 1H), 11.57
(s,1H);13C NMR(100MHz,CDCl3)δ30.81,87.30,109.26,111.32,115.07,118.00,121.77,
122.06,123.55,126.72,127.76,128.13,128.91,129.04,131.54,131.77,137.83,140.40,
141.46,143.50,149.18,160.74,202.08.
High resolution mass spec data: HRMS (ESI) calcd for C27H19N2O2(M+H)+:403.1441,found
403.1443.
Embodiment 2, the synthesis of IB
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant are selected pair respectively
Methoxy-phenylacetylene indol-2-one, 2- cyano-acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the use of raw material
Amount is respectively to Methoxy-phenylacetylene indol-2-one 0.3mmol, 2- cyano-acetophenone 0.33mmol, Cs2CO30.6mmol, solvent
Dimethyl sulfoxide 3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate is added
0.9mmol is placed at 60 DEG C and reacts 3 hours, obtains target product formula (IB), yellow solid, separation yield 70%.Mp 192-194
℃。
Nuclear magnetic data:1H NMR(400MHz,CDCl3) δ 3.69 (s, 3H), 4.26 (s, 3H), 6.62 (d, J=8.4Hz,
2H),7.05-7.10(m,2H),7.15-7.26(m,5H),7.38-7.43(m,1H),7.47-7.49(m,1H),7.54-7.58
(m, 1H), 8.43 (d, J=8.0Hz, 1H), 11.60 (s, 1H);13C NMR(100MHz,CDCl3)δ30.80,55.10,
87.11,109.22,111.06,113.62,115.11,118.26,121.82,122.01,123.47,126.60,127.75,
128.97,130.29,131.68,132.93,140.44,141.41,143.65,149.06,160.18,160.78,202.11.
High resolution mass spec data: HRMS (ESI) calcd for C28H21N2O3(M+H)+:433.1547,found
433.1557.
Embodiment 3, the synthesis of IC
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
Acetylene -6- Methvl-indole -2- ketone, 2- cyano-acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the use of raw material
Amount is respectively phenylacetylene -6- Methvl-indole -2- ketone 0.3mmol, 2- cyano-acetophenone 0.33mmol, Cs2CO30.6mmol, solvent
Dimethyl sulfoxide 3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate is added
0.9mmol is placed at 60 DEG C and reacts 3 hours, obtains target product formula (IC), yellow solid, separation yield 63%.Mp 202-204
℃。
Nuclear magnetic data:1H NMR(400MHz,CDCl3)δ2.48(s,3H),4.05(s,3H),6.91-7.01(m,5H),
7.05-7.16 (m, 7H), 8.13 (d, J=7.6Hz, 1H), 11.42 (s, 1H);13C NMR(100MHz,CDCl3)δ21.97,
30.56,87.14,109.35,111.22,114.92,118.01,119.26,122.97,123.45,127.66,128.02,
128.75,128.99,131.51,131.63,137.04,137.82,140.35,141.73,143.32,148.49,160.21,
201.99.
High resolution mass spec data: HRMS (ESI) calcd for C28H21N2O2(M+H)+:417.1598,found
417.1607.
Embodiment 4, the synthesis of ID
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
Acetylene -4- Methoxv-indole -2- ketone, 2- cyano-acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, raw material
Dosage is respectively phenylacetylene -4- Methoxv-indole -2- ketone 0.3mmol, 2- cyano-acetophenone 0.33mmol, Cs2CO30.6mmol、
Solvent dimethyl sulfoxide 3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, over cure is added
Sour ammonium 0.9mmol is placed at 60 DEG C and reacts 3 hours, obtains target product formula (ID), brown solid, separation yield 72%.Mp
280-281℃。
Nuclear magnetic data:1H NMR(400MHz,CDCl3) δ 3.98 (s, 3H), 4.13 (s, 3H), 6.70 (d, J=8.4Hz,
1H), 7.05 (d, J=8.4Hz, 1H), 7.14-7.23 (m, 7H), 7.32-7.41 (m, 2H), 7.59 (d, J=8.0Hz, 2H),
10.24(s,1H);13C NMR(100MHz,CDCl3)δ31.03,56.39,85.76,102.11,103.87,110.08,
110.20,118.17,120.11,127.88,128.13,128.40,128.64,129.49,130.09,133.20,136.68,
138.30,141.96,143.02,145.96,151.90,152.59,196.27.
High resolution mass spec data: HRMS (ESI) calcd for C28H21N2O3(M+H)+:433.1547,found
433.1540.
Embodiment 5, the synthesis of IE
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
The chloro- indol-2-one of acetylene -5-, 2- cyano-acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the dosage of raw material
Chloro- indol-2-one 0.3mmol, 2- cyano-acetophenone 0.33mmol, the Cs of respectively phenylacetylene -5-2CO30.6mmol, solvent diformazan
Sulfoxide 3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate is added
0.9mmol is placed at 60 DEG C and reacts 3 hours, obtains target product formula (IE), yellow solid, separation yield 64%.Mp 271-272
℃。
Nuclear magnetic data:1H NMR(400MHz,CDCl3)δ4.25(s,3H),7.04-7.11(m,5H),7.18-7.26(m,
5H), 7.38-7.41 (m, 1H), 7.49-7.52 (m, 1H), 8.38 (d, J=1.2Hz, 1H), 11.60 (s, 1H);13C NMR
(100MHz,CDCl3)δ31.00,87.50,110.27,110.60,115.14,117.69,122.77,123.08,126.86,
127.64,127.80,128.20,129.04,131.48,131.91,137.61,139.79,140.16,143.79,149.78,
160.86,201.92.
High resolution mass spec data: HRMS (ESI) calcd for C27H18N2O2Cl(M+H)+:437.1051,
found437.1051.
Embodiment 6, the synthesis of IF
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
The bromo- indol-2-one of acetylene -4-, 2- cyano-acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the dosage of raw material
Bromo- indol-2-one 0.3mmol, 2- cyano-acetophenone 0.33mmol, the Cs of respectively phenylacetylene -4-2CO30.6mmol, solvent diformazan
Sulfoxide 3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate is added
0.9mmol is placed at 60 DEG C and reacts 3 hours, obtains target product formula (IF), crocus solid, separation yield 77%.Mp 248-
250℃。
Nuclear magnetic data:1H NMR(400MHz,CDCl3)δ4.16(s,3H),7.08-7.13(m,5H),7.16-7.19(m,
2H),7.22-7.28(m,2H),7.33-7.39(m,3H),7.42-7.45(m,1H),10.29(s,1H);13C NMR
(100MHz,CDCl3)δ31.43,86.74,108.89,109.33,114.32,117.90,118.76,121.63,126.99,
127.55,128.14,128.17,128.94,129.24,130.53,132.68,136.74,139.12,143.29,143.53,
148.28,156.29,198.73.
High resolution mass spec data: HRMS (ESI) calcd for C27H18N2O2Br(M+H)+:481.0546,
found481.0561.
Embodiment 7, the synthesis of IG
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
Acetylene indol-2-one, 2- cyano melilotal, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the dosage of raw material
Respectively phenylacetylene indol-2-one 0.3mmol, 2- cyano melilotal 0.33mmol, Cs2CO30.6mmol, solvent diformazan
Sulfoxide 3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate is added
0.9mmol is placed at 60 DEG C and reacts 3 hours, obtains target product formula (IG), yellow solid, separation yield 55%.Mp 283-285
℃。
Nuclear magnetic data:1H NMR(400MHz,CDCl3) δ 2.21 (s, 3H), 4.26 (s, 3H), 6.5 (d, J=7.6Hz,
2H),7.09-7.16(m,5H),7.25-7.27(m,2H),7.37-7.42(m,1H),7.46-7.49(m,1H),7.54-7.58
(m, 1H), 8.42 (d, J=7.6Hz, 1H), 11.44 (s, 1H);13C NMR(100MHz,CDCl3)δ21.16,30.78,
87.09,109.19,111.29,115.25,118.11,121.74,121.96,123.52,126.65,128.03,128.42,
128.78,129.36,131.50,137.51,137.87,141.43,142.64,143.44,148.93,160.45,201.57.
High resolution mass spec data: HRMS (ESI) calcd for C28H20N2O2Na(M+Na)+:439.1417,
found439.1420.
Embodiment 8, the synthesis of IH
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
Acetylene indol-2-one, 2- cyano are to fluoro acetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the dosage of raw material point
Not Wei phenylacetylene indol-2-one 0.3mmol, 2- cyano to fluoro acetophenone 0.33mmol, Cs2CO30.6mmol, solvent dimethyl sulfoxide
3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate 0.9mmol is added,
It is placed at 60 DEG C and reacts 3 hours, obtain target product formula (IH), yellow solid, separation yield 60%.Mp 221-222℃.
Nuclear magnetic data:1HNMR(400MHz,CDCl3)δ4.26(s,3H),6.71-6.76(m,2H),7.13(brs,3H),
7.25 (brs, 4H), 7.38-7.43 (m, 1H), 7.47-7.50 (m, 1H), 7.55-7.59 (m, 1H), 8.42 (d, J=7.6Hz,
1H),11.44(s,1H);13C NMR(100MHz,CDCl3)δ30.80,87.32,109.27,111.34,114.85(JC-F=
22.1Hz),114.85,117.92,121.68,122.10,123.53,126.78,128.26,129.11,131.48,131.64
(JC-F=9.2Hz), 136.51,137.74,141.44,143.48,148.84,160.61,164.76 (JC-F=253.7Hz),
200.33.
High resolution mass spec data: HRMS (ESI) calcd for C27H17N2O2FNa(M+Na)+:443.1166,
found443.1168.
Embodiment 9, the synthesis of II
Indoles acetylenic ketone compounds, alpha-cyano ketone compounds, promotor, solvent, catalyst, oxidant select benzene respectively
Acetylene indol-2-one, 2- cyano parachloroacetophenone, Cs2CO3, dimethyl sulfoxide, ferrous bromide, ammonium persulfate, the dosage of raw material point
It Wei not phenylacetylene indol-2-one 0.3mmol, 2- cyano parachloroacetophenone 0.33mmol, Cs2CO30.6mmol, solvent dimethyl sulfoxide
3ml is reacted 2.5 hours at 100 DEG C, is then cooled to room temperature, and ferrous bromide 0.015mmol, ammonium persulfate 0.9mmol is added,
It is placed at 60 DEG C and reacts 3 hours, obtain target product formula (II), yellow solid, separation yield 74%.Mp 267-269℃.
Nuclear magnetic data:1H NMR(400MHz,CDCl3)δ4.22(s,3H),6.99-7.02(m,2H),7.12-7.15(m,
5H), 7.23-7.25 (m, 2H), 7.37-7.46 (m, 2H), 7.53-7.57 (m, 1H), 8.39 (d, J=7.6Hz, 1H), 11.51
(s,1H);13C NMR(100MHz,CDCl3)δ30.74,87.36,109.25,111.28,114.70,117.83,121.61,
122.09,123.46,126.75,127.96,128.25,129.14,130.35,131.51,137.65,137.89,138.60,
141.36,143.43,148.88,160.71,200.59.
High resolution mass spec data: HRMS (ESI) calcd for C27H18N2O2Cl(M+H)+:437.1051,
found437.1065.
Protection content of the invention is not limited to above embodiments.Without departing from the spirit and scope of the invention, originally
Field technical staff it is conceivable that variation and advantage be all included in the present invention, and with appended claims be protect
Protect range.
Claims (10)
1. cyano carbazole analog derivative, which is characterized in that shown in its structure such as formula (I):
Wherein, R1For electrophilic or electron substituent group, taken selected from phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy
The aryl or C1-C10 alkyl that aryl, the cyano that aryl, the halogen in generation replace replace;
R2For phenyl, hydrogen, halogen, C1-C10 alkyl or C1-C10 alkoxy;
R3The aryl or C1- that aryl, the halogen replaced for phenyl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy replaces
C10 alkyl.
2. the synthetic method of (I) cyano carbazole analog derivative shown in a kind of formula, which is characterized in that with indoles acetylenic ketone compounds
It is raw material with alpha-cyano ketone compounds, under the action of catalyst, promotor and oxidant, synthesis is obtained as shown in formula (I)
Cyano carbazole analog derivative, shown in reaction process such as formula (II):
Wherein,
R1For electrophilic or electron substituent group, the aryl replaced selected from the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy,
The aryl or C1-C10 alkyl of aryl, cyano substitution that halogen replaces;
R2For aryl, hydrogen, halogen, C1-C10 alkyl or C1-C10 alkoxy;
R3The aryl or C1- that aryl, the halogen replaced for aryl, the alkyl-substituted aryl of C1-C10, C1-C10 alkoxy replaces
C10 alkyl.
3. synthetic method as claimed in claim 2, which is characterized in that the specific steps are that: the first step, in a solvent, with Yin
Diindyl acetylenic ketone compounds and alpha-cyano ketone compounds are raw material, and C-C σ-bond activation occurs under promotor effect and obtains scission of link
Reaction intermediate;Oxidant, catalyst is added in second step, C-H and/or C-C bond activation occurs for selectivity, and synthesis obtains described
Cyano carbazole analog derivative.
4. synthetic method as claimed in claim 2 or claim 3, which is characterized in that the promotor be alkali, the alkali include DBACO,
K2CO3、Cs2CO3One of or it is a variety of.
5. synthetic method as claimed in claim 2 or claim 3, which is characterized in that the catalyst includes FeBr2、FeCl3、CuBr2
One of or it is a variety of.
6. synthetic method as claimed in claim 2 or claim 3, which is characterized in that the oxidant is peroxide, the peroxidating
Object includes K2S2O8、(NH4)2S2O8, one of TBHP or a variety of.
7. synthetic method as claimed in claim 3, which is characterized in that the solvent is n,N-Dimethylformamide, N, N- bis-
One of methylacetamide, dimethyl sulfoxide, toluene are a variety of.
8. synthetic method as claimed in claim 3, which is characterized in that the temperature reacted in the first step is 80-100 DEG C;
In the second step, the temperature of the reaction is 40-80 DEG C.
9. synthetic method as claimed in claim 3, which is characterized in that the time reacted in the first step is 2.5h;
In the second step, the time of the reaction is 3h.
10. synthetic method as claimed in claim 2, which is characterized in that the indoles acetylenic ketone compounds: alpha-cyano ketone
Close object: promotor: catalyst: the molar ratio of oxidant is 1:1.1:(1.5-3.0): (0.03-0.1): (2.0-4.0).
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810940607.6A CN108997197B (en) | 2018-08-17 | 2018-08-17 | Cyanocarbazole derivative and synthesis method thereof |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
CN201810940607.6A CN108997197B (en) | 2018-08-17 | 2018-08-17 | Cyanocarbazole derivative and synthesis method thereof |
Publications (2)
Publication Number | Publication Date |
---|---|
CN108997197A true CN108997197A (en) | 2018-12-14 |
CN108997197B CN108997197B (en) | 2021-12-07 |
Family
ID=64593584
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CN201810940607.6A Active CN108997197B (en) | 2018-08-17 | 2018-08-17 | Cyanocarbazole derivative and synthesis method thereof |
Country Status (1)
Country | Link |
---|---|
CN (1) | CN108997197B (en) |
Cited By (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113636972A (en) * | 2020-04-27 | 2021-11-12 | 华东师范大学 | Polysubstituted benzene compound and synthesis method thereof |
Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101260074A (en) * | 2008-04-09 | 2008-09-10 | 华东师范大学 | Non-substituted or tetra-substituted N-acyl-carbazoles compounds and synthesizing method thereof |
-
2018
- 2018-08-17 CN CN201810940607.6A patent/CN108997197B/en active Active
Patent Citations (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN101260074A (en) * | 2008-04-09 | 2008-09-10 | 华东师范大学 | Non-substituted or tetra-substituted N-acyl-carbazoles compounds and synthesizing method thereof |
Non-Patent Citations (5)
Title |
---|
JIAN LI,等: "Gold(III)-Catalyzed Regioselective Oxidation/Cycloisomerization of Diynes: An Approach to Fused Furan Derivatives", 《ORG. LETT.》 * |
JOHN T. R. LIDDON,等: "Catalyst-Driven Scaffold Diversity: Selective Synthesis of Spirocycles, Carbazoles and Quinolines from Indolyl Ynones", 《CHEM. EUR. J.》 * |
JOHN T. R. LIDDON,等: "Divergent Reactivity of Indole-Tethered Ynones with Silver(I) and Gold(I) Catalysts: A Combined Synthetic and Computational Study", 《SYNTHESIS》 * |
SITI FARAH MD TOHID,等: "Synthesis and evaluation of indole-containing 3,5-diarylisoxazoles as potential pro-apoptotic antitumour agents", 《EUROPEAN JOURNAL OF MEDICINAL CHEMISTRY》 * |
YAJIE YANG,等: "Synthesis of cyano-substituted carbazoles via successive C-C/C-H cleavage", 《ORG. BIOMOL. CHEM.》 * |
Cited By (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CN113636972A (en) * | 2020-04-27 | 2021-11-12 | 华东师范大学 | Polysubstituted benzene compound and synthesis method thereof |
CN113636972B (en) * | 2020-04-27 | 2023-11-10 | 华东师范大学 | Polysubstituted benzene compound and synthesis method thereof |
Also Published As
Publication number | Publication date |
---|---|
CN108997197B (en) | 2021-12-07 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
Chen et al. | Silver-catalyzed highly efficient synthesis of pyrido [1, 2-a] pyrimidin-4-ones from 2-aminopyridines and alkynoates | |
Jachak et al. | Friedländer condensation of 5‐aminopyrazole‐4‐carbaldehydes with reactive α‐methylene ketones: Synthesis of pyrazolo [3, 4‐b] pyridines | |
CN108997362A (en) | A kind of pyrans indolone simultaneously middle ring analog derivative and its synthetic method and application | |
CN108997197A (en) | A kind of cyano carbazole analog derivative and its synthetic method | |
CN108947945A (en) | A kind of 1,3- dihydroisobenzofuran derivative and its synthetic method and application | |
Fang et al. | Metal‐and Solvent‐Free Synthesis of Maleimide Fused Carbazoles from (Indol‐3‐Yl) cyclohexanones and Maleimides | |
Tan et al. | FeCl3‐Mediated One‐Pot Cyclization–Aromatization of Anilines, Benzaldehydes, and Phenylacetylenes under Ball Milling: A New Alternative for the Synthesis of 2, 4‐Diphenylquinolines | |
CN106866563B (en) | Method for preparing 2, 4-disubstituted-1, 3,5 triazine derivative | |
CN108440391B (en) | A kind of preparation method of 2,4,6- triaryl substituted pyridine derivative | |
CN109535140A (en) | A method of double indoles substituted-dihydro pyrrolones derivatives are constructed based on oxime ester and indoles | |
CN108997196B (en) | Carbazole derivative and synthesis method thereof | |
CN110483524A (en) | The preparation method of indolocarbazole class compound | |
CN105646326B (en) | A kind of preparation method of the ketone compounds of polysubstituted indoles 2 | |
CN107151226B (en) | A kind of preparation method of polysubstituted isoindolinone | |
CN108299303B (en) | Novel synthesis method of tetraarylpyrazole compound | |
Liao et al. | Green synthesis of polyhydroquinolines catalyzed by silica‐supported ionic liquid Si–[SbSipim][PF6] | |
CN107686475B (en) | Synthesis method of 2,3, 5-trisubstituted thiophene and derivatives thereof | |
CN107778238A (en) | A kind of new synthetic method of the ketone of 3,4 dihydro-isoquinoline 1 and isoindoline 1 ketone derivatives | |
CN115677696A (en) | Preparation method of benzonaphthyridine derivative | |
CN110724094A (en) | Quinoline compound and synthesis method thereof | |
CN106083649B (en) | A kind of synthetic method of the Cyclohexadiene derivatives of 3,5 diaryl, 2,6,6 tricyano, 1 imino group 2,4 | |
CN106986810B (en) | Chiral 3- replaces isoindoline ketone compound and the preparation method and application thereof | |
CN107118208B (en) | A kind of nitrogenous polycyclic fluorescent chemicals and preparation method thereof | |
CN110903288B (en) | Imidazaphenanthridine compound and preparation method and application thereof | |
CN114057650B (en) | Method for preparing 4, 5-dihydropyridazin-3-one compounds by one-pot method |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
PB01 | Publication | ||
PB01 | Publication | ||
SE01 | Entry into force of request for substantive examination | ||
SE01 | Entry into force of request for substantive examination | ||
GR01 | Patent grant | ||
GR01 | Patent grant |